PLG Antibody, Biotin Conjugated refers to a plasminogen-specific antibody chemically linked to biotin, a vitamin that forms high-affinity bonds with streptavidin or avidin. This conjugation process typically involves covalent attachment of biotin molecules to lysine residues or sulfhydryl groups on the antibody via NHS ester or maleimide chemistry . The resulting conjugate retains both the antibody's target specificity and biotin's utility for signal amplification.
Biotin-conjugated PLG antibodies enable sensitive detection and quantification in diverse assays:
Biotin Density Impact: Higher biotin labeling density (e.g., 6 µg/mL vs. 2 µg/mL) correlates with increased antibody binding efficiency and accelerated target detection, though excessive labeling may impair antibody specificity .
Signal Amplification: Biotin-streptavidin systems enhance sensitivity by ~10–100x compared to direct enzyme conjugates, critical for low-abundance plasminogen detection .
Cross-Reactivity: Polyclonal biotin-conjugated antibodies (common for PLG) may exhibit broader species reactivity (e.g., human, mouse, rat) but require rigorous validation to minimize off-target binding .